Quture/TCLN & Springhill Medical Center Jointly Announce Sale of Software License to Qualoptima
July 11 2012 - 7:00AM
Marketwired
Quture International, Inc. (OTCQB: TCLN)
(PINKSHEETS: TCLN) ("Quture") and
Springhill
Medical Center jointly announce the purchase of a license to
Quture's new clinical performance measurement product, QualOptima.
Springhill has licensed Quture's previous product QReview for over
five years. Now, with new regulatory mandates, hospitals previously
using peer review software must change to performance measurement.
Springhill selected Quture based on their successful experience
with the company's previous product and Quture's expertise in
clinical performance measurement. Quture's new "transformative" and
"disruptive" tool is introducing electronic performance measurement
to empower hospitals and surgery centers to measure clinical
performance on the
InterSystems Corporation
(www.InterSystems.com) technology platform. Rural medical centers
such as Springhill are now able to replace labor-intensive manual
processes with electronic data capture and analytics, while
integrating their peer review and performance measurement
processes.
"We have had an excellent relationship with Quture and their
previous QReview product," said Marilyn Mow, Assistant
Administrator of Springhill Medical Center. "We are excited to
purchase this new product to begin transitioning from existing
labor-intensive, anecdotal, and required quality and risk
management processes to electronic data analysis. The new Joint
Commission standards created our need to change to a performance
measurement product. We immediately contacted our vendor, now their
new corporation Quture, and we are excited that the Company has
developed this remarkable new software solution. We believe our
hospital and the community and patients we serve will benefit
extraordinarily by Quture's new analytics system."
Quture has completed migration from their former peer review
product onto the InterSystems technology platform and integrated
the performance measurement technology and intellectual property
demonstrated at the University of Miami with InterSystems.
InterSystems' interface engine Ensemble® is used for data
integration to capture clinical data electronic medical records and
disparate databases into the InterSystems CACHÉ® object-oriented
database. The InterSystems platform is aptly-suited to harness and
support the power of Quture's intellectual property. Additionally,
InterSystems' DeepSee™ dashboard for embedded real-time business
intelligence and Zen report writer complete the platform package
for health care enterprise management that is so desperately needed
by physicians, clinicians, administration, boards and the quality
and patient safety professionals in hospitals and physician groups
in America and internationally.
"We have now achieved a major milestone to move from product
development to a revenue-generating operational company," said
Landon Feazell, CEO of Quture International. "We are proud that
Springhill has selected Quture to continue meeting their needs for
compliance with mandated standards for measuring clinical
performance. Transitioning from peer review to performance
measurement has been the core competence of our companies for more
than 35 years. We are excited to be involved in the global movement
to improve care, transform quality of care endeavors, and reduce
costs using clinical performance measurement. We deeply appreciate
the efforts and successes with InterSystems to achieve this
remarkable milestone on their incredible technology platform."
ABOUT QUTURE INTERNATIONAL, INC.
(www.quture.com)
Quture International, Inc. is an emerging growth company
positioned to become the leading clinical knowledge company in the
world. The core competence of Quture is clinical performance
enhancement to achieve optimal patient outcomes. Quture's brand is
centered on the value proposition of trust, transparency and
independence. As the free enterprise solution to improving health
and health care while reducing costs, Quture is comprised of a
subsidiaries in North America and Europe for the operations of its
software technology solutions, plans for a "beyond data" consulting
and knowledge applications company, as well as plans for a
personalized, proactive, and predictive medicine company with a
virtual community of members. These subsidiaries will all be
affiliated with the Qx Medical Exchange, which the Company intends
to become the largest medical and health exchange in the world.
Quture International is a Nevada corporation currently trading
under the symbol TCLN.
ABOUT SPRINGHILL MEDICAL CENTER, SPRINGHILL,
LA (www.smccare.com)
Springhill Medical Center is a 58 bed facility offering
Medical/Surgical, Geriatric Psychiatric, ICU, and ER services. In
addition Springhill Medical Center offers full service Lab, X-Ray,
Physical Therapy and Respiratory departments. Two Rural Health
Clinics are home to 10 full-time healthcare providers and various
other specialty providers that come on a regular basis. The medical
center serves a large area of northwest Louisiana and parts of
Arkansas. SMC's mission is "Patient Centered Care From Our Family
To Yours." SMC's vision is "To be every patient's first choice for
healthcare excellence. We will adapt and expand services to create
healthier communities."
This release contains forward-looking statements, including,
without limitation, statements concerning our business and possible
or assumed future results of operations. Our actual results could
differ materially from those anticipated in the forward-looking
statements for many reasons including: our ability to continue as a
going concern, adverse economic changes affecting markets we serve;
competition in our markets and industry segments; our timing and
the profitability of entering new markets; greater than expected
costs, customer acceptance of our products or difficulties related
to our integration of the businesses we may acquire; and other
risks and uncertainties as may be detailed from time to time in our
public announcements and SEC filings. Although we believe the
expectations reflected in the forward-looking statements are
reasonable, they relate only to events as of the date on which the
statements are made, and our future results, levels of activity,
performance or achievements may not meet these expectations. We do
not intend to update any of the forward-looking statements after
the date of this document to conform these statements to actual
results or to changes in our expectations, except as required by
law. There is no assurance that a definitive agreement will be
completed.
For Further Information Contact: Constellation Asset
Advisors, Inc. Jens Dalsgaard President +1 (415) 524-8500 Mele
Telitz Director of Communications 303-204-4486 mele@quture.com